Nanox (NNOX) Announces Secondary Offering of Ordinary Shares

NANO-X IMAGING LTD (NASDAQ: NNOX), an innovative medical imaging technology company, today announced the commencement of a proposed underwritten public offering of 2,891,322 of its ordinary shares by certain non-officer, non-director shareholders.

Nanox is not selling any shares and will not receive any proceeds from the sale of its ordinary shares being offered by the selling shareholders. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Cantor Fitzgerald & Co. and Oppenheimer & Co. are acting as joint lead book-running managers for the offering. BTIG and Berenberg are acting as joint lead managers and Ladenburg Thalmann & Co. Inc. and LifeSci Capital are acting as co-managers for the offering.

You May Also Be Interested In

• Universe Pharmaceuticals (UPC) Files for 20M Share Offering by Selling Stockholders
• BTIG Downgrades DermTech Inc. (DMTK) to Neutral
• La Rosa Holdings (LRHC) Files for 6.95M Share Offering by Selling Stockholders